Shigetomo Yamada

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer

M. Shiota, A. Yokomizo, E. Kashiwagi, 2022, Prostate international.

Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, JMA journal.

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, Prostate international.

Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancer

K. Tatsugami, M. Hamaguchi, M. Yoshikawa, 2018, International journal of urology : official journal of the Japanese Urological Association.

Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer

M. Shiota, A. Yokomizo, A. Takeuchi, 2021, Anticancer Research.